Eisenmenger syndrome (ES) represents the most severe phenotype of pulmonary arterial
hypertension (PAH) associated with congenital heart disease (CHD) and occurs in patients …

Although major breakthroughs in the field of pediatric cardiology, cardiac surgery,
intervention, and overall care improved the outlook of congenital heart disease …

Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension
(PAH) associated with congenital heart disease, is a devastating condition that has a …

Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension and
arises on the basis of congenital heart disease with a systemic-to-pulmonary shunt. Due to …

Eisenmenger syndrome is the most severe and extreme phenotype of pulmonary arterial
hypertension associated with congenital heart disease. A large nonrestrictive systemic left-to …

Aims Eisenmenger syndrome (ES) is associated with considerable morbidity and mortality.
Therapeutic strategies have changed during the 2000s in conjunction with an emphasis on …

Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension and
arises on the basis of congenital heart disease with a systemic-to-pulmonary shunt. Due to …

Abstract Aims To characterize contemporary Eisenmenger patients at a large centre for adult
congenital heart disease, assess survival prospects, and identify predictors of death in this …

Without an understanding of the physiology of the Eisenmenger state (complex, syndrome or
reaction) the management and outcomes of such cases will not be optimal. This is a problem …

Background—Eisenmenger syndrome differs significantly from other types of pulmonary
arterial hypertension in its physiology and prognosis. We sought to assess the relationship …